Trials / Completed
CompletedNCT01205776
EXCEL Clinical Trial
Evaluation of XIENCE Versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization.
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 1,905 (actual)
- Sponsor
- Abbott Medical Devices · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To establish the safety and efficacy of the commercially approved XIENCE Family Stent System (inclusive of XIENCE PRIME, XIENCE V, XIENCE Xpedition and XIENCE PRO \[for use outside the United States \[OUS\] only\]) in subjects with unprotected left main coronary artery disease by comparing to coronary artery bypass graft surgery.
Conditions
- Chronic Coronary Occlusion
- Unprotected Left Main Coronary Artery Disease
- Stent Thrombosis
- Vascular Disease
- Myocardial Ischemia
- Coronary Artery Stenosis
- Coronary Disease
- Coronary Artery Disease
- Coronary Restenosis
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Percutaneous Coronary Intervention | Those patients receiving the XIENCE PRIME™ EECSS or XIENCE V® EECSS or XIENCE Xpedition™ EECSS or XIENCE PRO EECSS |
| PROCEDURE | CABG | Those patients receiving CABG |
Timeline
- Start date
- 2010-09-29
- Primary completion
- 2019-05-03
- Completion
- 2019-06-28
- First posted
- 2010-09-20
- Last updated
- 2020-04-07
- Results posted
- 2018-03-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01205776. Inclusion in this directory is not an endorsement.